Non-Interruptive Alerts for Improving Use of Clinical Decision Rules

November 16, 2023 updated by: Keaton Morgan, University of Utah

The Use of Non-Interruptive Alerts for Improving the Use of Clinical Decision Rules in the Emergency Department: A Cluster Randomized Controlled Trial

This study is an extension of a planned quality improvement project that aims to promote standard of care by increasing the use of evidence-based clinical decision rules amongst emergency medicine providers in the University of Utah Emergency Department. Patient-specific information from the EHR will be used to recommend the use of relevant clinical decision rules to emergency medicine providers at the point-of-care. These recommendations will be in the form of non-interruptive alerts with one-click access to the suggested decision rules through the MDCalc Connect EHR add-on application. Specific aims of the study are to determine if 1) patient-specific non-interruptive alerts increase the use of clinical decision rules amongst emergency medicine providers and 2) an increase in the use of clinical decision rules affects provider ordering habits.

Study Overview

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Utah
      • Salt Lake City, Utah, United States, 84112
        • University Of Utah

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Patient Inclusion Criteria:

  • 16 years of age or older
  • Qualifying chief complaint*

Patient Exclusion Criteria:

  • None

    • A full list of the qualifying chief complaints is provided in Appendix A of the full research protocol.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
The intervention will contain two components: 1) a non-interruptive best practice advisory (BPA) in the Epic Storyboard and 2) a default suggested calculator tab in the MDCalc Connect app. Six clinical decision rules will be included: Canadian CT Head Rule, Canadian C-spine Rule, HEART Score, PERC Rule, Wells' PE Criteria and Wells' DVT Criteria. Predefined criteria based on chief complaint, patient age and vital signs will be used to determine when a decision rule may be relevant in a patient encounter. When a patient meets all of the predefined criteria, the intervention will be triggered.
The
No Intervention: Control Group
The control group will be usual care. Specifically, providers in the control group will not receive the clinical decision rule alert or the default suggested calculator tab in the MDCalc Connect app. The control group providers will have access to the MDCalc Connect app in its standard form and functionality.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total clinical decision rule usage
Time Frame: During the intervention
Composite measure of total number of clinical decision rules used through the MDCalc Connect app.
During the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Individual clinical decision rule usage
Time Frame: During the intervention
Number of uses of individual clinical decision rules measured through the MDCalc Connect app.
During the intervention
Computed tomography pulmonary angiography studies
Time Frame: During the intervention
The total number of computed tomography pulmonary angiography studies ordered
During the intervention
Computed tomography head studies
Time Frame: During the intervention
The total number of computed tomography head without contrast studies ordered
During the intervention
Computed tomography c-spine studies
Time Frame: During the intervention
The total number of computed tomography c-spine without contrast studies ordered
During the intervention
Lower extremity ultrasound
Time Frame: During the intervention
The total number of lower extremity ultrasound studies ordered
During the intervention
d-dimer tests
Time Frame: During the intervention
Total number of d-dimer blood tests ordered
During the intervention
Delta troponin tests
Time Frame: During the intervention
Total number of times two or more troponin tests were ordered
During the intervention
Emergency department bounceback rate.
Time Frame: Up to 30 days after the intervention
30-day emergency department return visit (or "bounceback") rate
Up to 30 days after the intervention
Admission rate
Time Frame: During the intervention
Hospital admission rate
During the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 18, 2021

Primary Completion (Actual)

November 18, 2021

Study Completion (Actual)

November 4, 2022

Study Registration Dates

First Submitted

January 4, 2021

First Submitted That Met QC Criteria

January 6, 2021

First Posted (Actual)

January 8, 2021

Study Record Updates

Last Update Posted (Estimated)

November 20, 2023

Last Update Submitted That Met QC Criteria

November 16, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chest Pain

Clinical Trials on Clinical Decision Rule Alerts

3
Subscribe